scispace - formally typeset
Open AccessJournal ArticleDOI

Cancer statistics, 2018

TLDR
The combined cancer death rate dropped continuously from 1991 to 2015 by a total of 26%, translating to approximately 2,378,600 fewer cancer deaths than would have been expected if death rates had remained at their peak.
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2014, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2015, were collected by the National Center for Health Statistics. In 2018, 1,735,350 new cancer cases and 609,640 cancer deaths are projected to occur in the United States. Over the past decade of data, the cancer incidence rate (2005-2014) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2006-2015) declined by about 1.5% annually in both men and women. The combined cancer death rate dropped continuously from 1991 to 2015 by a total of 26%, translating to approximately 2,378,600 fewer cancer deaths than would have been expected if death rates had remained at their peak. Of the 10 leading causes of death, only cancer declined from 2014 to 2015. In 2015, the cancer death rate was 14% higher in non-Hispanic blacks (NHBs) than non-Hispanic whites (NHWs) overall (death rate ratio [DRR], 1.14; 95% confidence interval [95% CI], 1.13-1.15), but the racial disparity was much larger for individuals aged <65 years (DRR, 1.31; 95% CI, 1.29-1.32) compared with those aged ≥65 years (DRR, 1.07; 95% CI, 1.06-1.09) and varied substantially by state. For example, the cancer death rate was lower in NHBs than NHWs in Massachusetts for all ages and in New York for individuals aged ≥65 years, whereas for those aged <65 years, it was 3 times higher in NHBs in the District of Columbia (DRR, 2.89; 95% CI, 2.16-3.91) and about 50% higher in Wisconsin (DRR, 1.78; 95% CI, 1.56-2.02), Kansas (DRR, 1.51; 95% CI, 1.25-1.81), Louisiana (DRR, 1.49; 95% CI, 1.38-1.60), Illinois (DRR, 1.48; 95% CI, 1.39-1.57), and California (DRR, 1.45; 95% CI, 1.38-1.54). Larger racial inequalities in young and middle-aged adults probably partly reflect less access to high-quality health care. CA Cancer J Clin 2018;68:7-30. © 2018 American Cancer Society.

read more

Citations
More filters
Journal ArticleDOI

Ovarian cancer statistics, 2018.

TL;DR: Progress in reducing ovarian cancer incidence and mortality can be accelerated by reducing racial disparities and furthering knowledge of etiology and tumorigenesis to facilitate strategies for prevention and early detection.
Journal ArticleDOI

Breast cancer statistics, 2019.

TL;DR: Breast cancer was the leading cause of cancer death in women in four Southern and two Midwestern states among blacks and in Utah among whites during 2016‐2017, and could be accelerated by expanding access to high‐quality prevention, early detection, and treatment services to all women.
Journal ArticleDOI

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors.

TL;DR: Up-to-date statistics on pancreatic cancer occurrence and outcome along with a better understanding of the etiology and identifying the causative risk factors are essential for the primary prevention of this disease.
Journal ArticleDOI

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.

TL;DR: In this article, the safety and efficacy of the docetaxel-based triplet FLOT (fluorouracil plus leucovorin, oxaliplatin, and doceteaxel) as a perioperative therapy for patients with locally advanced, resectable tumours was reported.
References
More filters
Journal ArticleDOI

Cancer statistics, 2012

TL;DR: The reduction in overall cancer death rates since 1990 in men and 1991 in women translates to the avoidance of about 1,024,400 deaths from cancer, which can be accelerated by applying existing cancer control knowledge across all segments of the population, with an emphasis on those groups in the lowest socioeconomic bracket.
Journal ArticleDOI

Reduced lung-cancer mortality with low-dose computed tomographic screening.

TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.
Journal ArticleDOI

International Classification of Diseases for Oncology

TL;DR: Use ofImmunofluorescence in the Diagnosis of Virus Infections using audio-tape slide programme and slides and cassette by P. S. Gardner.
Journal ArticleDOI

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

TL;DR: The USPSTF recommends against PSA-based screening for prostate cancer (grade D recommendation), which applies to men in the general U.S. population, regardless of age.
Related Papers (5)
Trending Questions (2)
Which are the statistics for cancer today?

The paper provides statistics for cancer in the United States. In 2018, it is projected that there will be 1,735,350 new cancer cases and 609,640 cancer deaths. The cancer incidence rate has remained stable in women and declined by approximately 2% annually in men. The cancer death rate has declined by about 1.5% annually in both men and women. The overall cancer death rate dropped by 26% from 1991 to 2015. There is a racial disparity in cancer death rates, with non-Hispanic blacks having a higher death rate compared to non-Hispanic whites. The racial disparity is more pronounced in individuals aged <65 years. The racial inequalities in young and middle-aged adults may be due to less access to high-quality healthcare.

What are the current cancer statistics?

The current cancer statistics in the United States estimate 1,735,350 new cancer cases and 609,640 cancer deaths in 2018. The cancer incidence rate remained stable in women and declined by approximately 2% annually in men. The cancer death rate declined by about 1.5% annually in both men and women. The combined cancer death rate dropped by 26% from 1991 to 2015. Racial disparities in cancer death rates varied by age and state.